Understanding the nanotechnology in COVID-19 vaccines

by CAS, a division of the American Chemical Society

Lipid nanoparticles are a vital component of the new Pfizer/BioNTech and Moderna mRNA COVID-19 vaccines, playing a key role in protecting and transporting the mRNA effectively to the right place in ce...

Read more

Pall Corporation Invests $114M to Expand Global Production Capacity

by Pall Biotech

Pall Corporation expands production capacity in the United States and Europe to support industry demand

Read more

Oh, what a year it’s been! Lessons learned amid the pandemic

by CAS, a division of the American Chemical Society

We began 2020 refreshed and hopeful, with plans to publish unique perspectives and insights to inspire new ideas in the months to come—but COVID-19 changed everything. As the world adapted and recon...

Read more

Top 5 COVID-19 vaccine questions answered

by CAS, a division of the American Chemical Society

​Recent promising news on the efficacy and safety of COVID-19 vaccines provides a light at the end of the tunnel of the pandemic that has upended normal life around the globe throughout 2020. An mRN...

Read more

Sartorius raises forecast for the full year of 2020

by Sartorius

Stronger growth and higher profitability expected for the Bioprocess Solutions Division and the entire Group; outlook for the Lab Products & Services Division unchanged

Read more

Telstar MSC in TV NBC News report

by Telstar

Telstar microbiological safety cabinets are present in the most prominent laboratories around the world which are working on the research for vaccines to treat or prevent Covid-19.

Read more

Molecular Signatures Can Predict the Efficacy of Malaria Vaccines

by ISGlobal - Instituto de Salud Global de Barcelona

A new study reveals that it is possible to identify those individuals that will be protected by the vaccine before its administration

Read more

Pulmobiotics secures two-million-euro investment from Invivo Capital

by Centre for Genomic Regulation

Luis Serrano and Maria Lluch of the Centre for Genomic Regulation (CRG) in Barcelona have founded Pulmobiotics S.L., a pre-clinical life sciences company using synthetic biology to develop new treatme...

Read more

Designing multi-purpose vaccines: the MycoSynVac project concludes after five years

by Centre for Genomic Regulation

Scientists from the five-year EU funded project MycoSynVac report their findings and successes at a final meeting in Brussels. The project drew on cutting edge biotechnology to explore three important...

Read more

Nine Million Children Could Die in a Decade Unless World Acts on Pneumonia, Leading Agencies Warn

by ISGlobal - Instituto de Salud Global de Barcelona

Today starts the first ever global forum on childhood pneumonia in Barcelona, organised by the Barcelona Institute for Global Health together with eight international entities

Read more

The manufacturing process for Strangvac, the new vaccine against equine strangles, is proceeding according to plan

by 3P Biopharmaceuticals

The biotechnology company Intervacc has together with 3P Biopharmaceuticals, the contracted manufacturer of Strangvac, finalized the production of the drug substances on a commercial scale in complian...

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

Un hidrogel inyectado puede promover la ...

by DiCYT - Agencia Iberoamericana para la Difusión de la Ciencia y la Tecnología

El Grupo BIOFORGE de la UVa publica en la prestigiosa revista 'Science...

Photos Stream